United States v. Quality Formulation Laboratories, Inc. , 512 F. App'x 237 ( 2013 )


Menu:
  •                                                                NOT PRECEDENTIAL
    UNITED STATES COURT OF APPEALS
    FOR THE THIRD CIRCUIT
    ________________
    Nos. 11-4511, 11-4512 & 11-4513
    ________________
    UNITED STATES OF AMERICA
    v.
    QUALITY FORMULATION LABORATORIES, INC;
    AMERICAN SPORTS NUTRITION INC; MOHAMED S. DESOKY,
    Appellants (No. 11-4511)
    OMAR DESOKY,
    Appellant (No. 11-4512)
    AHMAD DESOKY,
    Appellant (No. 11-4513)
    ________________
    Appeal from the United States District Court
    for the District of New Jersey
    (D.C. Civil Action Nos. 2-10-cr-00699-001/2/4/5/6)
    District Judge: Honorable Garrett E. Brown, Jr.
    ________________
    Argued January 8, 2013
    Before: SCIRICA, AMBRO, and FUENTES, Circuit Judges
    (Opinion filed: January 25, 2013)
    Eric R. Breslin, Esquire
    Marco A. Gonzalez, Jr., Esquire (Argued)
    Duane Morris
    1037 Raymond Boulevard
    One Riverfront Plaza, Suite 1800
    Newark, NJ 07102
    Counsel for Appellants
    Quality Formulation Labs,
    American Sports Nutrition Inc.,
    Mohamed S. Desoky
    Lisa Van Hoeck, Esquire (Argued)
    Office of Federal Public Defender
    220 South Clinton Avenue
    Station Plaza #4, 4th Floor
    Trenton, NJ 08609
    Counsel for Omar Desoky, Appellant
    Ricardo Solano, Jr., Esquire (Argued)
    Friedman, Kaplan, Seiler & Adelman
    One Gateway Center, 25th Floor
    Newark, NJ 07102
    Counsel for Ahmad Desoky, Appellant
    Mark E. Coyne, Esquire
    David E. Dauenheimer, Esquire
    Office of United States Attorney
    970 Broad Street, Room 700
    Newark, NJ 07102
    Paul J. Fishman
    United States Attorney
    Stuart F. Delery
    Acting Assistant Attorney General
    Patrick R. Runkle, Esquire (Argued)
    United States Department of Justice
    Office of Consumer Litigation
    P.O. Box 386
    Washington, DC 20044
    Counsel for Appellee
    2
    ________________
    OPINION
    ________________
    AMBRO, Circuit Judge
    Appellants—three companies and three individuals—jointly appeal their
    convictions for criminal contempt and Appellants Omar and Ahmad Desoky appeal their
    sentences. We affirm the convictions but vacate and remand Omar and Ahmad Desoky’s
    sentences for further findings.
    I.     Background
    In 2010, following a civil suit, Mohamed Desoky and the three dietary supplement
    companies he ran—Quality Formulations Laboratories (QFL), American Sports Nutrition
    (ASN), and Sports Nutrition International (SNI)—entered into a court-approved Consent
    Decree with the federal Food and Drug Administration (FDA) halting production at the
    companies’ Paterson, New Jersey manufacturing facility. The Consent Decree provided
    that
    [QFL, ASN, SNI and Mohamed Desoky] and each and all of their officers, agents,
    employees, successors, and assigns, and any persons in active concert or
    participation with any of them who receive notice of this Decree, are permanently
    restrained and enjoined . . . from directly or indirectly receiving, manufacturing,
    preparing, packing, labeling, and distributing at their plant located [in] . . .
    Paterson, New Jersey . . . or any new location(s) at which the Defendants receive,
    manufacture, prepare, pack, label, hold, or distribute articles of food, any article of
    food unless and until [described] conditions have been met[.]
    App. at 78, Consent Decree, para. VII. It also required that
    [QFL, ASN, SNI and Mohamed Desoky] shall notify FDA in writing at least thirty
    (30) calendar days before any change [in] ownership, name, or character of their
    business, including reorganization, relocation, dissolution, assignment, or lease or
    3
    sale of the business or any asset of the business, such as buildings, equipment, or
    inventory, that may affect compliance with the obligations arising from this
    Decree.
    Id. at 92, Consent Decree, para. XV.
    Pursuant to the Consent Decree, the Paterson facility was shut down.
    Subsequently, manufacture of Appellants’ products began at a facility in Congers, New
    York owned by ADH Health Products (―ADH‖). On discovering this manufacturing, the
    FDA filed an order to show cause alleging criminal contempt by Mohamed, the three
    companies, and Mohamed’s two sons and company employees, Ahmad and Omar. The
    Government alleged that Appellants willfully violated the Consent Decree by
    manufacturing products at the Congers facility. Appellants asserted a good faith defense,
    arguing that they contracted with ADH to manufacture QFL products, and they believed
    this third-party manufacturing was permitted by the Consent Decree.
    Evidence presented at trial showed that the Congers facility manufactured QFL
    products, that Appellants sent raw material and equipment from Paterson to Congers, that
    former and current QFL employees worked on the products in Congers, and that QFL
    paid those employees in cash. Appellants did not disclose the activities at Congers to the
    FDA, including during two FDA inspections of the Paterson facility.
    In addition to the activities at Congers, some raw ingredients were shipped to the
    Paterson facility, Ahmad brought some products manufactured at ADH to the Paterson
    facility to be shipped to customers, and Ahmad loaded two pallets of product from the
    Paterson facility to a truck owned by Performance Food Centers. The Government
    4
    alleged that these actions also violated the Consent Decree, and Appellants asserted a
    good faith defense to these charges as well.
    Appellants were convicted of criminal contempt. Mohamed was sentenced to 40
    months’ imprisonment. Ahmad and Omar were each sentenced to 34 months’
    imprisonment, and the companies were fined. All appeal.1
    II.     Discussion
    Appellants raise four challenges to their convictions and one to a sentencing
    enhancement applied to Omar and Ahmad Desoky.
    A.     Exclusion of Mary Richardson’s Testimony
    The District Court excluded Appellants’ offered testimony of Mary Richardson, an
    expert consultant they hired to help them comply with the FDA’s requirements in order to
    avoid and then lift the production shut-down. Richardson would not have testified about
    the charged conduct. Instead, her testimony related solely to Appellants’ efforts to
    remediate the issues identified at the Paterson facility.
    We review a district court’s decision to admit evidence for abuse of discretion.
    United States v. Givan, 
    320 F.3d 452
    , 460 (3d Cir. 2003). Some evidence of earlier
    ―good acts‖ evidence may be admissible to show a defendant lacked wrongful intent in
    later behavior. See United States v. Garvin, 
    565 F.2d 519
    , 522 (8th Cir. 1977) (evidence
    of correctly submitted applications for approximately 18 insurance policies admissible to
    show lack of intent to commit a scheme to defraud); United States v. Shavin, 
    287 F.2d 1
    The District Court had jurisdiction pursuant to 
    18 U.S.C. § 3231
    , and we have appellate
    jurisdiction under 
    28 U.S.C. § 1291
    .
    5
    647, 654 (7th Cir. 1961) (evidence of properly submitted medical bills admissible to
    show lack of intent to defraud with later medical bills).
    But Richardson’s testimony is not of this sort. Evidence that Appellants
    undertook ameliorative efforts at Paterson does not negate the Government’s theory—
    apparently adopted by the jury—that Appellants engaged in simultaneous efforts to
    improve the Paterson plant and to continue manufacturing elsewhere, with the latter
    actions violating the Consent Decree.
    In addition, Richardson’s testimony would have raised ancillary issues about the
    initial problems at Paterson and the Appellants’ ameliorative efforts. The District Court
    concluded this outweighed any potentially probative value of the testimony. We agree,
    and, moreover, discern no harm in excluding Richardson’s testimony. United States v.
    Berrios, 
    676 F.3d 118
    , 131 (3d Cir. 2012). Appellants provided uncontradicted evidence
    at trial about their efforts at Paterson, and their counsel were able to argue to the jury that
    these efforts demonstrated their lack of willfulness to violate the decree. In this context,
    the District Court did not err in excluding the testimony.
    B.     Jury Instruction on a Good Faith Defense
    Appellants also challenge two aspects of the jury charge on their good faith
    defense. They argue that the Court improperly instructed the jury: (1) that an honest
    misunderstanding of the order must be plausible; and (2) that a defendant does not act in
    good faith if he also knowingly made false statements, representations, or purposeful
    omissions. The first part we review de novo because Appellants objected to the language
    at trial. United States v. Berrios, 
    676 F.3d at 136
    . Appellants contend that we should
    6
    review the false statements instructions de novo because they omit key language in their
    requested charge. While we doubt that merely requesting an instruction contrary to the
    one given sufficiently informs the Court of the specific objection, thus preserving the
    issue for appeal, Fed. R. Crim. P. 30(d); United States v. Russell, 
    134 F.3d 171
    , 178–79
    (3d Cir. 1998), we discern no error under either a de novo or plain error review.
    The language used by the District Court on plausibility comes from our analysis of
    a good faith defense in Taberer v. Armstrong World Industries, Inc., 
    954 F.2d 888
    , 909
    (3d Cir. 1992). Although Appellants allege error in this instruction, we consider jury
    instructions as a whole, and here find that the jury was properly instructed that a
    defendant did not commit criminal contempt if he acted under an honest, although
    incorrect, misunderstanding of the court order. United States v. Gross, 
    961 F.2d 1097
    ,
    1103 (3d Cir. 1992) (―[T]he good faith instruction [i]s simply a reiteration that the
    government must carry its burden in demonstrating that the accused acted knowingly and
    willfully . . . .‖). We also find no error in the Court’s instruction that a defendant does
    not act in good faith if he makes false statements, representations, or purposeful
    omissions. As such, there is no support for Appellants’ argument that the jury might
    have determined that they were not entitled to a good faith defense because of a false
    statement or omission unrelated to the charged conduct.
    C.     Sufficiency of the Evidence on the Aiding and Abetting Charge
    Omar and Ahmad challenge the sufficiency of the evidence that they aided and
    abetted the other Appellants’ failure to notify the FDA of the companies’ relocation from
    Paterson to Congers. When reviewing a jury verdict for insufficiency of evidence, we
    7
    consider the evidence in a light most favorable to the Government, and will affirm unless
    no reasonable jury could find the essential elements of the charged offense beyond a
    reasonable doubt. United States v. Gatlin, 
    613 F.3d 374
    , 380 (3d Cir. 2010). Aiding and
    abetting has four elements. ―First, the person who is being aided must be intentionally
    committing a crime; second, the aider or abettor must know that the other is committing a
    crime; third, the aider or abettor must have the purpose to aid that other to commit the
    crime; and, finally, fourth, the aider must in fact render aid or assistance.‖ United States
    v. Nolan, 
    718 F.2d 589
    , 592 (3d Cir. 1983). Sufficient evidence was presented at trial
    for a reasonable jury to conclude that all four elements were met. Omar and Ahmad
    knew that Mohamed had failed to inform the FDA of the move to Congers, a violation of
    the Consent Decree, and they successfully assisted him and the other Appellants in
    concealing the relocation.
    D.     Closing Arguments
    Appellants also argue that the prosecutors made a number of improper statements
    during closing argument. We review a district court’s ruling on contemporaneous
    objections to the statements for abuse of discretion. United States v. Brennan, 
    326 F.3d 176
    , 182 (3d Cir. 2003). To determine whether a district court abused its discretion, we
    must consider whether the prosecutor engaged in misconduct, and, if so, whether the
    remarks were harmless. United States v. Rivas, 
    493 F.3d 131
    , 139–40 (3d Cir. 2007).
    We review statements to which Appellants did not object for plain error. Brennan, 
    326 F.3d at 182
    . Although we are troubled by the prosecutor’s reference to defense counsels’
    attack on a witness’s credibility as ―disgusting‖ and ―ridiculous,‖ we do not think this
    8
    statement alone, or in combination with the other challenged comments, prejudiced
    Appellants. The other challenged comments do not amount to misconduct, nor have
    Appellants shown prejudice as a result of these statements, alone or in combination.
    E.      Sentencing Enhancement Applied to Omar and Ahmad
    Omar and Ahmad also challenge the District Court’s application of a three-level
    enhancement under section 3B1.1(b) of the United States Sentencing Guidelines. We
    review the factual findings supporting a district court’s application of the Guidelines for
    clear error, and exercise plenary review over a court’s interpretation of the Guidelines.
    United States v. Grier, 
    475 F.3d 556
    , 570 (3d Cir. 2007) (en banc). Section 3B1.1(b)
    provides for an enhancement ―[i]f the defendant was a manger or supervisor‖ and the
    criminal activity was extensive. U.S.S.G. § 3B1.1(b). It is applicable in two situations.
    First, the enhancement is proper if the defendant is a ―manager, or supervisor of one or
    more other participants.‖ § 3B1.1(b) cmt. 2. A participant is defined as someone who is
    ―criminally responsible for the commission of the offense‖ even if not convicted.
    § 3B1.1(b) cmt. 1; United States v. Katora, 
    981 F.2d 1398
    , 1404–05 (3d Cir. 1992). In
    addition, the defendant must have more than legal management responsibility over the
    participant; he must have actually managed or supervised the participant’s illegal
    conduct. United States v. DeGovanni, 
    104 F.3d 43
    , 44 (3d Cir. 1997) (―[O]ne is only a
    supervisor under U.S.S.G. § 3B1.1(c) when he is so involved in, and connected to, the
    illegal activity of others that he actually supervises their illegal conduct . . . .‖).
    Alternately, the role enhancement applies if the defendant ―exercised management
    9
    responsibility over the property, assets, or activities of a criminal organization.‖ § 3B1.1
    cmt. 2.
    Here the District Court determined that the criminal activity was extensive, but did
    not make any factual findings regarding whether Omar or Ahmad managed or supervised
    the unlawful activities of a criminally culpable participant or that a criminal organization
    existed over which Omar and Ahmad exercised management responsibility. Moreover,
    the Court did not determine whether the two unindicted employees the Government
    asserts were managed or supervised were criminally culpable. To sort matters out, we
    remand so the District Court can make necessary factual determinations.
    We thus affirm Appellants’ convictions. However, we vacate Omar and Ahmad
    Desoky’s sentences, and remand for further factual findings.
    10